-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on March 11
Philips executive changes
Recently, Philips announced that Shz Partovi will succeed Jeroen Tas as Chief Innovation and Strategy Officer, formally join the Philips Executive Committee and report directly to CEO Frans van Houten.
This schedule will take effect on July 1, 2021.
This schedule will take effect on July 1, 2021.
The new Chief Innovation and Strategy Officer, Partovi, was a neuroradiologist at the Barrow Neurological Institute and was engaged in clinical practice until 2013.
After that, Partovi worked in Dignity Health, the fifth largest healthcare system in the United States, for 20 years, and joined Amazon in 2018.
After that, Partovi worked in Dignity Health, the fifth largest healthcare system in the United States, for 20 years, and joined Amazon in 2018.
Partovi mainly serves as the global director of healthcare , life sciences and medical equipment business development at Amazon, and is responsible for Amazon's global marketing.
It is understood that the former chief innovation and strategy officer Jeroen Tas will also continue to hold a position at Philips, and his future direction of work is to guide digital projects.
At the same time, Philips’ current head of strategic business development and former head of Philips’ diagnostic and treatment department, Rob Cascella, will withdraw from the executive committee as planned and will withdraw from the company on April 1 this year.
Or will sell the business
At the same time as the executive changes, the news that Philips may sell its related businesses is also worthy of attention.
In September 2020, European media reported that Philips is in contact with competing mainland rivals Haier, Midea and other companies to determine whether they are interested in acquiring Philips’ home appliance division, which may be sold for up to 4 billion US dollars , The formal sale process is expected to begin in the fourth quarter of 2020.
The CEO of Philips has previously stated that Philips hopes to focus on the medical technology business in the future.
The home appliance business and the group's strategy no longer match, so it is considering selling its home appliance division.
The home appliance business and the group's strategy no longer match, so it is considering selling its home appliance division.
Prior to this, in May 2016, Philips stated that it would spin off its lighting equipment division for an initial public offering.
That month, Philips spin off its lighting business and listed on the Amsterdam Stock Exchange in the Netherlands.
That month, Philips spin off its lighting business and listed on the Amsterdam Stock Exchange in the Netherlands.
Focusing on the medical business step by step seems to be the strategic direction of Philips in recent years.
Philips' medical business includes businesses such as diagnosis and treatment, connected care, and personal health .
Philips CEO Fransvan Houten said that due to the impact of the epidemic, although Philips received a shock to its business in the first half of the year, its performance in the second half of the year remained strong.
Philips CEO Fransvan Houten said that due to the impact of the epidemic, although Philips received a shock to its business in the first half of the year, its performance in the second half of the year remained strong.
On January 25, Philips released a financial report showing that in 2020, Philips’ annual sales reached 19.
535 billion euros (about 153.
625 billion yuan), a year-on-year increase of 3%.
The annual net profit reached 1.
195 billion euros (about 9.
398 billion yuan), a year-on-year increase of 1.
9%.
535 billion euros (about 153.
625 billion yuan), a year-on-year increase of 3%.
The annual net profit reached 1.
195 billion euros (about 9.
398 billion yuan), a year-on-year increase of 1.
9%.
According to the financial report, in order to expand connected medical solutions, Philips acquired BioTelemetry and capsule in 2020.
The CEO of Philips publicly stated that the four strategic areas that the group will focus on in the future are the field of imaging diagnosis, artificial intelligence radiology platform, remote monitoring and care, and personal health management.
Medical Network News on March 11
Philips executive changes
Recently, Philips announced that Shz Partovi will succeed Jeroen Tas as Chief Innovation and Strategy Officer, formally join the Philips Executive Committee and report directly to CEO Frans van Houten.
This schedule will take effect on July 1, 2021.
This schedule will take effect on July 1, 2021.
The new Chief Innovation and Strategy Officer, Partovi, was a neuroradiologist at the Barrow Neurological Institute and was engaged in clinical practice until 2013.
After that, Partovi worked in Dignity Health, the fifth largest healthcare system in the United States, for 20 years, and joined Amazon in 2018.
After that, Partovi worked in Dignity Health, the fifth largest healthcare system in the United States, for 20 years, and joined Amazon in 2018.
Partovi mainly serves as the global director of healthcare , life sciences and medical equipment business development at Amazon, and is responsible for Amazon's global marketing.
It is understood that the former chief innovation and strategy officer Jeroen Tas will also continue to hold a position at Philips, and his future direction of work is to guide digital projects.
At the same time, Philips’ current head of strategic business development and former head of Philips’ diagnostic and treatment department, Rob Cascella, will withdraw from the executive committee as planned and will withdraw from the company on April 1 this year.
Or will sell the business
At the same time as the executive changes, the news that Philips may sell its related businesses is also worthy of attention.
In September 2020, European media reported that Philips is in contact with competing mainland rivals Haier, Midea and other companies to determine whether they are interested in acquiring Philips’ home appliance division, which may be sold for up to 4 billion US dollars , The formal sale process is expected to begin in the fourth quarter of 2020.
The CEO of Philips has previously stated that Philips hopes to focus on the medical technology business in the future.
The home appliance business and the group's strategy no longer match, so it is considering selling its home appliance division.
The home appliance business and the group's strategy no longer match, so it is considering selling its home appliance division.
Prior to this, in May 2016, Philips stated that it would spin off its lighting equipment division for an initial public offering.
That month, Philips spin off its lighting business and listed on the Amsterdam Stock Exchange in the Netherlands.
That month, Philips spin off its lighting business and listed on the Amsterdam Stock Exchange in the Netherlands.
Focusing on the medical business step by step seems to be the strategic direction of Philips in recent years.
Philips' medical business includes businesses such as diagnosis and treatment, connected care, and personal health .
Philips CEO Fransvan Houten said that due to the impact of the epidemic, although Philips received a shock to its business in the first half of the year, its performance in the second half of the year remained strong.
Philips CEO Fransvan Houten said that due to the impact of the epidemic, although Philips received a shock to its business in the first half of the year, its performance in the second half of the year remained strong.
On January 25, Philips released a financial report showing that in 2020, Philips’ annual sales reached 19.
535 billion euros (about 153.
625 billion yuan), a year-on-year increase of 3%.
The annual net profit reached 1.
195 billion euros (about 9.
398 billion yuan), a year-on-year increase of 1.
9%.
535 billion euros (about 153.
625 billion yuan), a year-on-year increase of 3%.
The annual net profit reached 1.
195 billion euros (about 9.
398 billion yuan), a year-on-year increase of 1.
9%.
According to the financial report, in order to expand connected medical solutions, Philips acquired BioTelemetry and capsule in 2020.
The CEO of Philips publicly stated that the four strategic areas that the group will focus on in the future are the field of imaging diagnosis, artificial intelligence radiology platform, remote monitoring and care, and personal health management.
Medical Network News on March 11
Philips executive changes
Philips executive changes Recently, Philips announced that Shz Partovi will succeed Jeroen Tas as Chief Innovation and Strategy Officer, formally join the Philips Executive Committee and report directly to CEO Frans van Houten.
This schedule will take effect on July 1, 2021.
This schedule will take effect on July 1, 2021.
The new Chief Innovation and Strategy Officer, Partovi, was a neuroradiologist at the Barrow Neurological Institute and was engaged in clinical practice until 2013.
After that, Partovi worked in Dignity Health, the fifth largest healthcare system in the United States, for 20 years, and joined Amazon in 2018.
After that, Partovi worked in Dignity Health, the fifth largest healthcare system in the United States, for 20 years, and joined Amazon in 2018.
Partovi mainly serves as the global director of healthcare , life sciences and medical equipment business development at Amazon, and is responsible for Amazon's global marketing.
Health Health Care It is understood that the former chief innovation and strategy officer Jeroen Tas will also continue to hold a position at Philips, and his future direction of work is to guide digital projects.
At the same time, Philips’ current head of strategic business development and former head of Philips’ diagnostic and treatment department, Rob Cascella, will withdraw from the executive committee as planned and will withdraw from the company on April 1 this year.
Or will sell the business
Or will sell the business At the same time as the executive changes, the news that Philips may sell its related businesses is also worthy of attention.
In September 2020, European media reported that Philips is in contact with competing mainland rivals Haier, Midea and other companies to determine whether they are interested in acquiring Philips’ home appliance division, which may be sold for up to 4 billion US dollars , The formal sale process is expected to begin in the fourth quarter of 2020.
Enterprise business enterprise The CEO of Philips has previously stated that Philips hopes to focus on the medical technology business in the future.
The home appliance business and the group's strategy no longer match, so it is considering selling its home appliance division.
The home appliance business and the group's strategy no longer match, so it is considering selling its home appliance division.
Prior to this, in May 2016, Philips stated that it would spin off its lighting equipment division for an initial public offering.
That month, Philips spin off its lighting business and listed on the Amsterdam Stock Exchange in the Netherlands.
That month, Philips spin off its lighting business and listed on the Amsterdam Stock Exchange in the Netherlands.
Focusing on the medical business step by step seems to be the strategic direction of Philips in recent years.
Philips' medical business includes businesses such as diagnosis and treatment, connected care, and personal health .
Philips CEO Fransvan Houten said that due to the impact of the epidemic, although Philips received a shock to its business in the first half of the year, its performance in the second half of the year remained strong.
Healthy, healthy, healthyPhilips CEO Fransvan Houten said that due to the impact of the epidemic, although Philips received a shock to its business in the first half of the year, its performance in the second half of the year remained strong.
On January 25, Philips released a financial report showing that in 2020, Philips’ annual sales reached 19.
535 billion euros (about 153.
625 billion yuan), a year-on-year increase of 3%.
The annual net profit reached 1.
195 billion euros (about 9.
398 billion yuan), a year-on-year increase of 1.
9%.
535 billion euros (about 153.
625 billion yuan), a year-on-year increase of 3%.
The annual net profit reached 1.
195 billion euros (about 9.
398 billion yuan), a year-on-year increase of 1.
9%.
According to the financial report, in order to expand connected medical solutions, Philips acquired BioTelemetry and capsule in 2020.
The CEO of Philips publicly stated that the four strategic areas that the group will focus on in the future are the field of imaging diagnosis, artificial intelligence radiology platform, remote monitoring and care, and personal health management.
